Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | REN | P00797 | 3/20 | 0.35 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.35 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.34 |
| ▸ | STK25 | O00506 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8135105 | 0.98 | MAPK1 (0.38) | MAPK1KMT2AL3MBTL1RENSMPD1 | |
| SCHEMBL8129418 | 0.97 | KMT2A (0.37) | MAPK1KMT2AL3MBTL1SMPD1LPAR1 | |
| SCHEMBL8126783 | 0.94 | KMT2A (0.36) | MAPK1KMT2AL3MBTL1RENSMPD1 | |
| SCHEMBL8128380 | 0.94 | KMT2A (0.39) | MAPK1KMT2AL3MBTL1LPAR1HDAC1 | |
| SCHEMBL8133459 | 0.92 | MAPK1 (0.38) | MAPK1SMPD1LPAR1STK25HDAC1 | |
| SCHEMBL8119996 | 0.92 | LPAR1 (0.41) | MAPK1KMT2AL3MBTL1LPAR1 | |
| SCHEMBL8131084 | 0.91 | LPAR1 (0.41) | MAPK1KMT2AL3MBTL1LPAR1 | |
| SCHEMBL8122551 | 0.91 | KMT2A (0.35) | MAPK1KMT2AL3MBTL1SMPD1LPAR1 | |
| SCHEMBL8133835 | 0.91 | MAPK1 (0.40) | MAPK1 | |
| SCHEMBL8123324 | 0.90 | PLA2G4B (0.40) | MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0763524-B1 | Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use | SANKYO CO (JP) | 2000-08-23 | — | — | EP | disclosed |
| US-6040339-A | TREATMENT AND PROPHYLAXIS OF HYPERCHOLESTEREMIA OR ARTERIOSCLEROSIS IN A MAMMAL | SANKYO COMPANY, LIMITED (JP) | 2000-03-21 | — | — | US | disclosed |
| EP-0763524-A1 | Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use | SANKYO COMPANY LIMITED (JP) | 1997-03-19 | — | — | EP | disclosed |